Invention Grant
- Patent Title: RNA sequence adaptation
-
Application No.: US16762081Application Date: 2018-11-08
-
Publication No.: US11692002B2Publication Date: 2023-07-04
- Inventor: Stefan Heinz , Tilmann Roos , Dominik Vahrenhorst , Markus Conzelmann
- Applicant: CureVac SE
- Applicant Address: DE Tübingen
- Assignee: CureVac SE
- Current Assignee: CureVac SE
- Current Assignee Address: DE Tübingen
- Agency: Parker Highlander PLLC
- Priority: WO TEP2017078647 2017.11.08
- International Application: PCT/EP2018/080692 2018.11.08
- International Announcement: WO2019/092153A 2019.05.16
- Date entered country: 2020-05-06
- Main IPC: C07H1/06
- IPC: C07H1/06 ; A61K31/713 ; C12Q1/68

Abstract:
The present invention is directed to a method for modifying the retention time of RNA on a chromatographic column. The present invention also concerns a method for purifying RNA from a mixture of at least two RNA species. Furthermore, the present invention relates to a method for co-purifying at least two RNA species from a mixture of at least two RNA species. In particular, the present invention provides a method for harmonizing the numbers of A and/or U nucleotides in at least two RNA species. The present invention is also directed to RNA obtainable by said methods, a composition comprising said RNA or a vaccine comprising said RNA and methods for producing such RNA and compositions. Further, the invention concerns a kit, particularly a kit of parts, comprising the RNA, composition or vaccine. The invention is further directed to a method of treating or preventing a disorder or a disease, first and second medical uses of the RNA, composition and vaccine. Moreover, the present invention concerns a method for providing an adapted RNA sequence or an adapted RNA mixture.
Public/Granted literature
- US20220144877A1 RNA SEQUENCE ADAPTATION Public/Granted day:2022-05-12
Information query